CGI
ABMD

CI Global Investments’s Abiomed Inc ABMD Stock Holding History

CI Global Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$11K Hold
24
– – ﹤0.01% 85
2018
Q2 		$10K Buy
24
+4
+20% +$1.45K ﹤0.01% 96
2018
Q1 		$6K Sell
20
-5
-20% -$1.27K ﹤0.01% 99
2017
Q4 		$5K Sell
25
-40
-62% -$7.47K ﹤0.01% 95
2017
Q3 		$11K Sell
65
-10
-13% -$1.51K ﹤0.01% 86
2017
Q2 		$11K Buy
+75
New +$10.1K ﹤0.01% 101

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

CI Global Investments's ABMD Position: Q3 2018 in Review

CI Global Investments held its Abiomed Inc (ABMD) position steady in Q3 2018 at 24 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #85.

CI Global Investments first reported a position in ABMD in Q2 2017 and has held it in 6 quarters since. 529 funds tracked by Wall St. Rank hold ABMD as of Q3 2018.

  • CI Global Investments held 24 shares of Abiomed Inc worth $11K as of Q3 2018.
  • CI Global Investments left its Abiomed Inc share count unchanged in Q3 2018.
  • Abiomed Inc made up ﹤0.01% of CI Global Investments's portfolio in Q3 2018, its #85 holding.
  • CI Global Investments first reported a position in Abiomed Inc in Q2 2017 and has held it in 6 quarters since.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2018.

Based on CI Global Investments's 13F filing for Q3 2018, filed 9 Nov 2018.